Blood cancer patients least likely to understand their diagnosis
People with blood cancer are less likely to understand their diagnosis than those with any other type of cancer, according to a new analysis by Bloodwise.
Aug 20, 2018
0
0
People with blood cancer are less likely to understand their diagnosis than those with any other type of cancer, according to a new analysis by Bloodwise.
Aug 20, 2018
0
0
Cancer cells are more than a lump of cells growing out of control; they participate in active combat with the immune system for their own survival. Being able to evade the immune system is a hallmark of cancer. Cancer cells ...
Aug 8, 2018
0
745
For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains ...
Jul 16, 2018
0
27
Bystander cells present in human lung and colorectal tumors could indicate how well a patient will respond to immunotherapy, an A*STAR-led study finds.
Jul 16, 2018
0
10
Scientists have discovered that it is possible to identify people at high risk of developing acute myeloid leukaemia (AML) years before diagnosis. The researchers from Wellcome Sanger Institute, European Bioinformatics Institute ...
Jul 9, 2018
0
45
A study has identified how kidney cancers may develop the ability to spread around the body by hijacking genes from other cell types and 'stealing' their functions.
Jun 7, 2018
0
224
Our immune system's arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate defense system.
May 30, 2018
0
63
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.
May 25, 2018
0
47
Targeted treatments have revolutionized care for lung cancer patients whose tumors harbor ALK or ROS1 alterations. Basically, cancers may use these genetic changes to drive their growth, but also become dependent on the action ...
Apr 11, 2018
0
25
In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression. The study, published ...
Apr 5, 2018
0
873